Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Reinforce the antitumor activity of CD 8+ T cells via glutamine restriction

Open access
Nabe, Shogo, Yamada, Takeshi, Suzuki, Junpei, Toriyama, Koji, Yasuoka, Toshiaki, Kuwahara, Makoto, Shiraishi, Atsushi, Takenaka, Katsuto, Yasukawa, Masaki, Yamashita, Masakatsu · 2018 · Cancer Science

Abstract

The antitumor activity of activated CD 8+ T cells in the tumor microenvironment seems to be limited due to their being metabolically unfit. This metabolic unfitness is closely associated with T‐cell exhaustion and impairment of memory formation, which are barriers to successful antitumor adoptive immunotherapy. We therefore assessed the role of glutamine metabolism in the antitumor activity of CD 8+ T cells using a tumor‐inoculated mouse model. The adoptive transfer of tumor‐specific CD 8+ T cells cultured under glutamine‐restricted (dG ln) conditions or CD 8+ T cells treated with specific inhibitors of glutamine metabolism efficiently eliminated tumors and led to better survival of tumor‐inoculated mice than with cells cultured under control (Ctrl) conditions. The decreased expression of PD‐1 and increased Ki67 positivity among tumor‐infiltrating CD 8+ T cells cultured under dG ln conditions suggested that the inhibition of glutamine metabolism prevents CD 8+ T‐cell exhaustion in vivo. Furthermore, the transferred CD 8+ T cells cultured under dG ln conditions expanded more efficiently against secondary OVA stimulation than did CD 8+ T cells under Ctrl conditions. We found that the expression of a pro‐survival factor and memory T cell‐related transcription factors was significantly higher in CD 8+ T cells cultured under dG ln conditions than in those cultured under Ctrl conditions. Given these findings, our study uncovered an important role of glutamine metabolism in the antitumor activity of CD 8+ T cells. The novel adoptive transfer of tumor‐specific CD 8+ T cells cultured in glutamine‐restricted conditions may be a promising approach to improve the efficacy of cell‐based adoptive immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cas.13827

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 175

Metadata

Authors
Nabe, S., Yamada, T., Suzuki, J., Toriyama, K., Yasuoka, T., Kuwahara, M., Shiraishi, A., Takenaka, K., Yasukawa, M., & Yamashita, M.
Venue
Cancer Science
Publisher
Wiley
Published
2018-11-02
Volume
109
Issue
12
Pages
3737-3750
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2897325901
Cited by
175
References
15
FWCI
3.96
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reinforce the antitumor activity of CD 8+ T cells via glutamine restriction. https://app.cochat.ai/papers/10.1111/cas.13827
The paper
Nabe, S., Yamada, T., Suzuki, J., Toriyama, K., Yasuoka, T., Kuwahara, M., Shiraishi, A., Takenaka, K., Yasukawa, M., & Yamashita, M. (2018). Reinforce the antitumor activity of CD 8+ T cells via glutamine restriction. Cancer Science. https://doi.org/10.1111/cas.13827

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.